VOLZELO - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
78851320
Word Mark
VOLZELO
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2011-03-21
Filing Date
2006-03-31
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2007-11-27
Attorney Name
Law Office Assigned Location Code
L20
Employee Name
WEBSTER, WILLIAM M
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2006-04-06
Primary Code
005
Correspondences
Name
Christopher L. Graff
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2006-04-06 | NEW APPLICATION ENTERED IN TRAM |
| 2006-09-13 | ASSIGNED TO EXAMINER |
| 2006-09-13 | NON-FINAL ACTION WRITTEN |
| 2006-09-13 | NON-FINAL ACTION E-MAILED |
| 2007-03-13 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2007-03-13 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2007-03-13 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2007-03-14 | FINAL REFUSAL WRITTEN |
| 2007-03-14 | FINAL REFUSAL E-MAILED |
| 2007-09-12 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2007-09-12 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2007-09-12 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2007-09-13 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2007-09-18 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2007-09-29 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2007-10-19 | ASSIGNED TO LIE |
| 2007-10-19 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2007-11-07 | NOTICE OF PUBLICATION |
| 2007-11-27 | PUBLISHED FOR OPPOSITION |
| 2007-11-30 | FAX RECEIVED |
| 2007-12-07 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| 2008-02-19 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| 2008-08-12 | TEAS EXTENSION RECEIVED |
| 2008-08-12 | EXTENSION 1 FILED |
| 2008-08-12 | EXTENSION 1 GRANTED |
| 2009-01-22 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2009-01-22 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2009-02-13 | TEAS EXTENSION RECEIVED |
| 2009-03-03 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2009-02-13 | EXTENSION 2 FILED |
| 2009-03-03 | EXTENSION 2 GRANTED |
| 2009-06-17 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2009-08-12 | TEAS EXTENSION RECEIVED |
| 2009-08-12 | EXTENSION 3 FILED |
| 2009-08-13 | EXTENSION 3 GRANTED |
| 2010-02-04 | TEAS EXTENSION RECEIVED |
| 2010-02-04 | EXTENSION 4 FILED |
| 2010-02-11 | EXTENSION 4 GRANTED |
| 2010-08-16 | TEAS EXTENSION RECEIVED |
| 2010-08-16 | EXTENSION 5 FILED |
| 2010-08-24 | EXTENSION 5 GRANTED |
| 2010-08-25 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2010-10-13 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2011-03-21 | ABANDONMENT - NO USE STATEMENT FILED |
| 2011-03-21 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 2011-03-23 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2014-01-22 | TEAS REVOKE/APPOINT ATTORNEY RECEIVED |
| 2014-01-22 | ATTORNEY REVOKED AND/OR APPOINTED |
